| Primary |
| Chronic Obstructive Pulmonary Disease |
35.6% |
| Asthma |
20.2% |
| Product Used For Unknown Indication |
16.3% |
| Dyspnoea |
3.8% |
| Emphysema |
3.8% |
| Lung Disorder |
3.8% |
| Convulsion |
2.9% |
| Oxygen Saturation Decreased |
2.9% |
| Prophylaxis |
1.9% |
| Bronchial Hyperreactivity |
1.0% |
| Bronchiectasis |
1.0% |
| Bronchitis |
1.0% |
| Cough |
1.0% |
| Diabetes Mellitus |
1.0% |
| Fungal Infection |
1.0% |
| Pneumonia |
1.0% |
| Seasonal Allergy |
1.0% |
| Urticaria |
1.0% |
|
| White Blood Cell Count Increased |
15.4% |
| Product Quality Issue |
12.8% |
| Pharmaceutical Product Complaint |
7.7% |
| Tachycardia |
7.7% |
| Cardiac Disorder |
5.1% |
| Heart Rate Irregular |
5.1% |
| Hypersensitivity |
5.1% |
| Tremor |
5.1% |
| Troponin Increased |
5.1% |
| Wheezing |
5.1% |
| Aggression |
2.6% |
| Arthralgia |
2.6% |
| Condition Aggravated |
2.6% |
| Dizziness |
2.6% |
| Dyspnoea |
2.6% |
| Economic Problem |
2.6% |
| Electrocardiogram St-t Change |
2.6% |
| Fear |
2.6% |
| Headache |
2.6% |
| Hypoprothrombinaemia |
2.6% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
39.9% |
| Asthma |
22.5% |
| Dyspnoea |
7.2% |
| Occupational Asthma |
5.8% |
| Emphysema |
4.3% |
| Oxygen Saturation Decreased |
3.6% |
| Wheezing |
2.9% |
| Blood Pressure |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Smoking Cessation Therapy |
2.2% |
| Hypertension |
1.4% |
| Hypothyroidism |
1.4% |
| Pain |
1.4% |
| Asthma Exercise Induced |
0.7% |
| Breast Cancer |
0.7% |
| Bronchiectasis |
0.7% |
| Osteoporosis |
0.7% |
|
| Vomiting |
15.4% |
| Stomatitis |
10.3% |
| Pharmaceutical Product Complaint |
7.7% |
| Tremor |
7.7% |
| Weight Decreased |
7.7% |
| Weight Increased |
7.7% |
| Gingival Recession |
5.1% |
| Rash |
5.1% |
| Vertigo |
5.1% |
| Condition Aggravated |
2.6% |
| Drug Effect Decreased |
2.6% |
| Dyspnoea |
2.6% |
| Food Allergy |
2.6% |
| Heart Rate Increased |
2.6% |
| Increased Upper Airway Secretion |
2.6% |
| Laboratory Test Abnormal |
2.6% |
| Mitral Valve Disease |
2.6% |
| Multiple Allergies |
2.6% |
| Nausea |
2.6% |
| Pericardial Effusion |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.8% |
| Drug Use For Unknown Indication |
21.0% |
| Asthma |
13.0% |
| Chronic Obstructive Pulmonary Disease |
6.0% |
| Gastrooesophageal Reflux Disease |
3.3% |
| Hypersensitivity |
3.2% |
| Pain |
3.1% |
| Hypertension |
2.7% |
| Osteoporosis |
1.7% |
| Wheezing |
1.6% |
| Laryngeal Cancer Metastatic |
1.4% |
| Depression |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Supplementation Therapy |
1.2% |
| Diabetes Mellitus |
1.2% |
| Pulmonary Arterial Hypertension |
1.2% |
| Back Pain |
1.0% |
| Dyspnoea |
1.0% |
| Emphysema |
1.0% |
| Multiple Allergies |
1.0% |
|
| Vomiting |
13.5% |
| Pneumonia |
10.6% |
| Dyspnoea |
9.6% |
| Hypersensitivity |
6.7% |
| Respiratory Failure |
5.8% |
| Urticaria |
5.8% |
| Injection Site Haematoma |
4.8% |
| Pruritus |
4.8% |
| Weight Decreased |
4.8% |
| Product Adhesion Issue |
3.8% |
| Wheezing |
3.8% |
| Dysgeusia |
2.9% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Haemorrhage |
2.9% |
| Heart Valve Calcification |
2.9% |
| Radiotherapy |
2.9% |
| Road Traffic Accident |
2.9% |
| Swelling Face |
2.9% |
| Syncope |
2.9% |
| Throat Irritation |
2.9% |
|
| Interacting |
|
|
